These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4392344)

  • 41. [Cardiovascular agents. 9. Effects of 1-tert-butylamino-3-(O-tetrahydrofurfuryloxy) phenoxy)-2-propanol hydrochloride (Y-6124) on experimental arrhythmia in dogs].
    Nakanishi M; Imamura H; Nakamura T
    Nihon Yakurigaku Zasshi; 1972 Mar; 68(2):240-53. PubMed ID: 4403394
    [No Abstract]   [Full Text] [Related]  

  • 42. [Significance of adrenal catecholamines for reflex cardiovascular counterregulation in rats with renal hypertension].
    Brunner H; Hedwall PR
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 265(5):387-96. PubMed ID: 4392043
    [No Abstract]   [Full Text] [Related]  

  • 43. Antiarrhythmic and hemodynamic effects of an aminosteroid (Org 3001) in the digitalized dog.
    Remme WJ; Verdouw PD; Hagemeyer F
    Eur J Pharmacol; 1976 Mar; 36(1):189-97. PubMed ID: 1261591
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MS-551 and KCB-328, two class III drugs aggravated adrenaline-induced arrhythmias.
    Xue Y; Yamada C; Aye NN; Hashimoto K
    Br J Pharmacol; 1998 Aug; 124(8):1712-8. PubMed ID: 9756388
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antiarrhythmic activity of flestolol, a novel ultra-short-acting beta-adrenoceptor antagonist, in the dog.
    Reynolds RD; Brown BS
    Eur J Pharmacol; 1986 Nov; 131(1):55-66. PubMed ID: 2880726
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Selective inhibition of 2 -adrenergic receptors by 1-(2,4-dimethylanilino)-3-isopropylamino-2-propanol.
    Sinha JN; Rastogi VK; Parmar SS
    Eur J Pharmacol; 1972 Aug; 19(2):285-7. PubMed ID: 5071799
    [No Abstract]   [Full Text] [Related]  

  • 47. Antiarrhythmic effects of tiapamil and propranolol assessed from the reduction of ventricular arrhythmias in the cycloergometer test. A double-blind study.
    Cocco G; De Gori D; Burkart F; Leishman B
    Cardiology; 1982; 69 Suppl():181-6. PubMed ID: 6185223
    [No Abstract]   [Full Text] [Related]  

  • 48. [Cardiovascular effects of alprenolol(beta-blockade) under halothane anesthesia].
    Yoshida T; Kubota M; Tamura A; Suzuki K; Furukawa Y
    Masui; 1969 Nov; 18(11):1071-8. PubMed ID: 4391283
    [No Abstract]   [Full Text] [Related]  

  • 49. Evaluation of antiarrhythmic and other cardiac activities in some newly synthesized quinazolone compounds.
    Singh N; Kulshrestha VK; Shamsi MA; Kohli RP; Bhargava KP
    Arch Int Pharmacodyn Ther; 1972; 198(1):94-106. PubMed ID: 5053244
    [No Abstract]   [Full Text] [Related]  

  • 50. Antiarrhythmic actions of two new beta adrenergic blocking agents, Kö 1313 and Kö 1366.
    Baum T; Rowles G; Shropshire AT
    J Pharmacol Exp Ther; 1971 Feb; 176(2):350-60. PubMed ID: 4105546
    [No Abstract]   [Full Text] [Related]  

  • 51. [Pharmacological studies with 1-isopropylamino-3-(o-allyloxyphenoxy)-2-propanol-hydrochloride, an adrenergic beta-receptor blocking agent].
    Brunner H; Hedwall PR; Meier M
    Arzneimittelforschung; 1968 Feb; 18(2):164-70. PubMed ID: 5695373
    [No Abstract]   [Full Text] [Related]  

  • 52. [The effect of 1-(isopropylamino)-3-(m-toyloxy)-2-propanol hydrochloride (Doberol) on the bronchial system after oral administration].
    Günthner W
    Eur J Clin Pharmacol; 1972 Jun; 4(3):185-90. PubMed ID: 4144065
    [No Abstract]   [Full Text] [Related]  

  • 53. General and coronary haemodynamic effects of 1-(O-allyloxphenoxy)-3-isopropylamino-2-propanol hydrochloride.
    Maxwell GM
    Arch Int Pharmacodyn Ther; 1968 May; 173(1):226-31. PubMed ID: 5657822
    [No Abstract]   [Full Text] [Related]  

  • 54. [Antiarrhythmic properties of 3-(2-hydroxy-3 isopropylamino-propoxy)-3 phenyl-2 isoindolinone-1, (RS, SR) in the dog].
    Detaille JY; Caillard CG; Mondot S; Louis JC; Julou L
    C R Seances Acad Sci D; 1979 Feb; 288(5):555-8. PubMed ID: 108025
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of tiprenolol, practolol and propranolol on experimental ventricular tachyarrhythmias.
    Allen JD; Shanks RG
    Br J Pharmacol; 1974 Jun; 51(2):179-85. PubMed ID: 4155971
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New N-isopropyl and N-tert.-butyl-phenoxypropanolaminic derivatives having -adrenolytic, anti-arrhythmic and local anaesthetic activity.
    Marmo E; Caputi AP; Saini RK
    Arzneimittelforschung; 1972 Jul; 22(7):1109-17. PubMed ID: 4404342
    [No Abstract]   [Full Text] [Related]  

  • 57. [Propafenon, a new antiarrhythmic agent for the treatment of ectopic and rapid cardiac arrhythmias (author's transl)].
    Beck OA
    Med Klin; 1975 Jan; 70(3-2):95-101. PubMed ID: 48183
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treadmill exercise in dogs under -adrenergic blockade: adaptation of coronary and systemic hemodynamics.
    Bassenge E; Kucharczyk M; Holtz J; Stoian D
    Pflugers Arch; 1972; 332(1):40-55. PubMed ID: 4401667
    [No Abstract]   [Full Text] [Related]  

  • 59. Absence of sensitization to epinephrine-induced cardiac arrhythmia and fibrillation in dogs and cats anesthetized with CI 744.
    Smith RD; Pettway CE
    Am J Vet Res; 1975 May; 36(5):695-8. PubMed ID: 1137214
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antiarrhythmic actions of a long acting verapamil analogue, anipamil, in pigs.
    Ries C; Harvie CJ; Walker MJ; Pugsley MK
    Proc West Pharmacol Soc; 1993; 36():95-8. PubMed ID: 8378404
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.